Clinical Study: International Identify Breast Cancer (IDBC) Study
Clinical studies are ongoing in Calgary, Canada; Manchester, UK; and Seoul, South Korea.
Methodology
Through the ongoing IDBC prospective international clinical study (NCT04495244), whole blood samples (2.5 ml) from 2,100 participants are being analyzed using Syantra DX™ Breast Cancer. The participant group includes women aged 25 to 80 years with no breast surgery in the past year and no previous cancer diagnosis except non-melanoma skin cancer. Blood samples are collected around the time of screening mammography and before any biopsies or surgeries.
